Clinical Trials Directory

Trials / Completed

CompletedNCT00046384

Study of Aripiprazole in the Treatment of Patients With Acute Symptoms of Bipolar Disorder

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to learn if aripiprazole is effective in the treatment of patients with acute symptoms of Bipolar Disorder.

Conditions

Interventions

TypeNameDescription
DRUGaripiprazole

Timeline

Start date
2002-06-01
Primary completion
2003-04-01
Completion
2003-04-01
First posted
2002-10-01
Last updated
2013-11-11

Locations

14 sites across 2 countries: United States, Argentina

Source: ClinicalTrials.gov record NCT00046384. Inclusion in this directory is not an endorsement.